The US pharmaceutical company Geron is about to start the world’s first human trial of embryonic stem cells, with a view to improving spinal cord injury.
Guests:
Dr Jane Lebkowski, Chief Scientific Officer, Geron
Dr Chris Mason, University College London
Disclaimer
The BBC is not responsible for the content of external websites.
